Lexapro and Gentamicin sulfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Gentamicin sulfate (gentamicin sulfate). Common drug interactions include asthenia among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lexapro and Gentamicin sulfate. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.

What is Gentamicin sulfate?

Gentamicin sulfate has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 3,942 Gentamicin sulfate users. Check the latest studies of Gentamicin sulfate.



On Jul, 10, 2026

19 people who take Lexapro and Gentamicin sulfate together, and have interactions are studied.

Lexapro and Gentamicin sulfate drug interactions.

What are the common drug interactions of Lexapro and Gentamicin Sulfate, by gender? *:

female:

  1. Asthenia (weakness)
  2. Pain in extremity
  3. Rash pruritic (redness with itching)
  4. Abasia (inability to walk)
  5. Abdominal wound dehiscence (abdominal wound ruptures)
  6. Chronic kidney disease
  7. Death
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dermatitis infected (inflammation of the skin due to infection)
  10. Device related infection

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Blood creatinine increased
  4. Emotional distress
  5. Pain
  6. Renal impairment (severely reduced kidney function)
  7. Renal injury (kidney injury)
  8. Dysstasia (difficulty in standing)
  9. Fall
  10. Gait disturbance

What are the common drug interactions of Lexapro and Gentamicin Sulfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Bone disorder
  6. Death

40-49:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Blood creatinine increased
  4. Emotional distress
  5. Pain
  6. Renal impairment (severely reduced kidney function)
  7. Renal injury (kidney injury)
  8. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Renal failure (kidney dysfunction)

50-59:

n/a

60+:

  1. Fall
  2. Gait disturbance
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Mobility decreased (ability to move is reduced)
  5. Ototoxicity (damage to the ear)
  6. Performance status decreased
  7. Abasia (inability to walk)
  8. Abdominal wound dehiscence (abdominal wound ruptures)
  9. Chronic kidney disease
  10. Death

What are the existing conditions these people have? *

  1. Pain: 6 people, 31.58%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 26.32%
  3. Hypersensitivity: 3 people, 15.79%
  4. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 3 people, 15.79%
  5. Bacterial Infection: 3 people, 15.79%
  6. Erection Problems: 3 people, 15.79%
  7. Fluid Retention (an abnormal accumulation of fluid in the blood): 3 people, 15.79%
  8. Asthma: 3 people, 15.79%
  9. Sleep Disorder: 3 people, 15.79%
  10. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Lexapro and Gentamicin sulfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lexapro and Gentamicin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gentamicin sulfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gentamicin sulfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and gentamicin sulfate (the active ingredients of Lexapro and Gentamicin sulfate, respectively), and Lexapro and Gentamicin sulfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: